Three-step pretargeting methods using improved biotin-active age

Details Three-step pretargeting methods using improved biotin-active age Three-step pretargeting methods using improved biotin-active age

1993-11-23

1996-11-26

Eisenschenk, Frank C.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Attached to antibody or antibody fragment or immunoglobulin;...

424 9363, 424 153, 5483037, 514387, 540474, 5303915, 5303913, 5303911, A61K 5110, A61K 31415, C07K 1630, C07D25702

Patent

active

055782876

ABSTRACT:
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, three-step pretargeting methods are described.

REFERENCES:
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 4923985 (1990-05-01), Gansow et al.
patent: 5141966 (1992-08-01), Porath
patent: 5246692 (1993-09-01), Gansow et al.
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5326778 (1994-07-01), Rosebrough
Rosebrough, May 13, 1992, J. Nuclear Medicine, 33(5):880, Abstract 235.
Wolf et al., Meth. Enzym., 1990, 184:103.
Harris et al., 1993, Tibtech, 11:42.
Osband et al., Immunol. Today, 1990, 11:193.
Dermer, 1994, Biotechnology, 12:320.
Bloom, 1993, J. Clin. Invest., 91:1265.
Moore, 1991, Cancer, 67:2718.
Chatterjee, Cancer Immunol. Immunopathol., 1994, 38:75-82.
Curti, Crit. Rev. Oncol. Hematol., 1993, 14:29-39.
Jain, Scientific American, 1994, 271(1):58-65.
Zwierzina, Stem Cells, 1993, 11:144-153.
S. F. Rosebrough, "Plasma Stability and Pharmacokinetics of Radiolabeled Deferoxamine-Biotin Derivatives", J. Pharmacol. Exp. Ther., vol. 265, No. 1, Apr. 1993, pp. 408-415.
J. A. Sanderson et al, "Preparation and Characterization of Biotin Conjugates of Antipan-Carcinoma NR-LU-10 Monoclonal Antibody for a Three Step Radioimmunotherapy", J. Nucl. Med., vol. 33, 5th Suppl., Abstract 222, p. 880, May 13, 1992.
Sheldon et al., Appl. Radiat. Isot., vol. 43, No. 11, pp. 1399-1402, 1992, "Targeting of [.sup.IIII n]Biocytin to Cultured Ovarian Adenocarcinoma Cells Using Covalent Monoclonal Antibody-Streptavidin Conjugates."
Goodwin, J. Nucl. Med., vol. 33, No. 10, pp. 1816-1818, 1992, "New Methods for Localizing Infection: A role for Avidin-Biotin?".
Goodwin, et al., J. Nucl. Med., vol. 33, No. 11, pp. 2006-2013, 1992, "Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake."
McMurry et al., Bioconjugate Chem., vol. 3, No. 2, pp. 108-117, 1992, "Convenient Synthesis of Bifunctional Tetraaza Macrocycles."
Renn and Meares, Bioconjugate Chem., vol. 3, No. 6, pp. 563-569, 1992, "Large-Scale Synthesis of the Bifunctional Chelating Agent 2-(p-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic Acid, and the Determination of Its Enatiomeric Purity by Chiral Chromatography.".
Koch and Macke, Angew. Chem. Intl. Ed. Engl., vol. 31, No. 11, pp. 1507-1509, 1992, ".sup.99m Tc Labeled Biotin Conjugate in a Tumor Pretargeting Approach with Monoclonal antibodies."
Wu et al., Nucl. Med. Biol. Int. J. Radiat. Appl. Instrum. Part B, vol. 19, No. 2, pp. 239-244, 1992, "Investigations of N-Linked Macrocycles for .sup.IIII In and .sup.90 Y Labeling of Proteins."
Goodwin et al., J. Nucl. Med., p. 880, 1992, Abstract No. 232, "Pharmacokinetics of Biotin-Chelate Conjugates for Pretargeted Avidin-Biotin Immunoscintigraphy."
Dischino et al., Inorg. Chem., vol. 30, pp. 1265-1269, 1992, "Synthesis of Nonionic Gadolinium Chelates Useful as Contrast Agents for Magnetic Resonance Imaging."
Sieving et al., Bioconjugate Chem., vol. 1, pp. 65-71, 1990, "Preparation and Characterization of Paramagnetic Polychelates and Their Protein Conjugates".
Parker et al., Pure & Appl. Chem., vol. 61, No. 9, pp. 1637-1641, 1989, "Implementation of macrocyclic conjugated antibodies for tumour-targeting. "
Riesen et al., J. Chem. Soc., Chem. Commun., pp. 460-462, 1989, "Synthesis and X-Ray Structural Characterization of Seven Co-ordinate Macrocyclic In.sup.3+ Complexes with Relevance to Radiopharmaceutical Applications."
Moi and Meares, J. Am. Chem. Soc., vol. 110, pp. 6267-6269, 1988, "The Peptide Way to Macrocyclic Bifunctional Chelating Agents: Synthesis of 2-(p-Nitrobenzy1)-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic Acid and Study of Its Yttrium (III) Complex."
Kasprzyk and Wilkins, Inorg. Chem., vol. 21, pp. 3349-3352, 1982, "Kinetics of Interaction of Metal Ions with Two Tetraaza Tetraacetate Macrocycles."
Green, Biochem. J., 89:585, 1963, "The Use of [.sup.14 C]Biotin for Kinetic Studies and for Assay."
Kalofonos et al., J. Nucl. Med., vol. 31, No. 11, pp. 1791-1796, 1990, "Imaging of Tumor in Patients with Indium-111-Labeled Biotin and Streptavidin-Conjugated Antibodies: Preliminary Communication."
Hnatowich et al., J. Nucl. Med., vol. 28, No. 8, pp. 1294-1302, 1987, "Investigations of Avidin and Biotin for Imaging Applications.".
Paganelli et al., Int. J. Cancer, 45:1184-1189, 1990, "Intraperitoneal Radio-Localization of Tumors Pre-Targeted by Biotinylated Monoclonal Antibodies."
Paganelli et al., Nuclear Medicine Communications, 12:211-234, 1991, "Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system."
Goodwin/Hnatowich, J. Nucl. Med., vol. 32, No. 4, pp. 750-751, 1991, Letter to the Editor/Reply.
Rosebrough, J. Nucl. Med., p. 880, 1992, Abstract No. 235, "Plasma Stability and Pharmacokinetics of Radio-Labeled Deferoxamine-Biotin Derivatives."
Virzi et al., J. Nucl. Med., p. 920, 1992, Abstract No. 403, "The Preparation and Evaluation of 12 Biotin Derivatives Labeled with Tc-99M."
Rosario et al., J. Nucl. Med., vol. 32, No. 5, p. 993, 1991, Abstract No. 356, "Bolton-Hunter and Biotin Derivatized Polylysine: A New Multi-Valent Peptide Reagent for In Vivo Pre-Targeting with Streptavidin Conjugates."5
Burns, Doane, Swecker & Mathis, L.L.P.

Affiliated with

Also associated with

Rating

Three-step pretargeting methods using improved biotin-active age does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Three-step pretargeting methods using improved biotin-active age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Three-step pretargeting methods using improved biotin-active age will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1971047